Revisions to the EUC Policy To Determine Quality Performance (1) Background In the CY 2026 PFS proposed rule (90 FR 32686), we stated that the current Shared Savings Program quality EUC policies are codified in the regulation at 425.512(c)
You have three administration options: Option A: Injectable GHK-Cu only 200 to 600 mcg per day, subcutaneous Best for systemic tissue support (skin, joints, hair, internal tissues) No fasting required Option B: Topical GHK-Cu only Applied to target areas once or twice daily Best for localized skin concerns (face, abdomen, specific areas of laxity) Lower cost, no injection required Option C: Injectable plus topical (recommended for maximum benefit) Injectable for systemic support plus topical for targeted skin areas Most thorough approach Addresses both internal tissue health and external skin quality Step 4: Improve and Maintain As semaglutide is titrated up over the following months, continue GHK-Cu consistently
This tolerance gap has a strategic consequence
AOD-9604 5MG GHK-CU/BPC-157/TB-500 GLOW Blend GLOW Blend (GHK-Cu, BPC-157, TB-500) is a research-grade peptide formulation containing ~70 mg per vial and verified at 99% purity
A B12 injection bypasses digestion entirely, allowing the body to use the vitamin immediately
